Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Equity (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Return on Equity data on record, last reported at 0.05% in Q3 2022.

  • For Q3 2022, Return on Equity rose 1.0% year-over-year to 0.05%; the TTM value through Sep 2022 reached 0.05%, up 1.0%, while the annual FY2021 figure was 0.19%, N/A changed from the prior year.
  • Return on Equity reached 0.05% in Q3 2022 per AVIR's latest filing, up from 0.02% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.19% in Q4 2021 and bottomed at 0.05% in Q4 2020.
  • Average Return on Equity over 3 years is 0.05%, with a median of 0.05% recorded in 2021.
  • Peak YoY movement for Return on Equity: grew 23bps in 2021, then fell -4bps in 2022.
  • A 3-year view of Return on Equity shows it stood at 0.05% in 2020, then soared by 504bps to 0.19% in 2021, then plummeted by -71bps to 0.05% in 2022.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.05% in Q3 2022, 0.02% in Q2 2022, and 0.07% in Q1 2022.